#MedicalNicotine

348,601 "ever-#snus users had about 60% lower Parkinson's disease risk compared with never-snus users."
https://t.co/YHB9FKkUtQ

30,000 British doctors followed for 60 years: "current smokers at baseline had a 30% lower risk of

#MedicalNicotine

Nicotine is beneficial for people with #ADHD. Research on adults and adolescents with ADHD shows that nicotine patches improve focus and attention, and reduce hyperactivity & impulsivity.
https://t.co/0mTHFftmDf
#MedicalNicotine

Nicotine reduces symptoms of Alzheimer's disease (AD).
https://t.co/Tht2Y8CZiN
#MedicalNicotine

Nicotine is beneficial for people with schizophrenia. More than 70% of people with schizophrenia smoke.

#SaferNicotine alternatives could help them as therapy, and to not die from smoking.
https://t.co/lNH75kqGGM
#MedicalNicotine

Nicotine, "(either 2 mg nicotine gum or 7 mg transdermal nicotine patch) potentiates [enhances] the therapeutic properties of neuroleptics in treating Tourette's syndrome... A single patch may be effective for a variable number of days."
https://t.co/lBJztxciio
#MedicalNicotine

Nicotine promotes weight loss. It is "associated with ...increased energy expenditure as a result of increased locomotor activity, increased thermogenesis in brown adipose tissue (BAT), and alterations in fuel substrate utilization."
https://t.co/jNufO6rFdq
#MedicalNicotine

Nicotine helps smokers quit (and thus not die). Nicotine patches & gum increase smoking cessation success (5% for cold turkey; 9% for patches & gum... but many relapse by 3 years). Longer-term quit efficacy for nicotine vapes is ~20%.
https://t.co/tnNUufg80Y
#MedicalNicotine

Nicotine patch therapy may be an effective treatment in #epilepsy patients who have nAChR gene variants.
https://t.co/gGCpX96QSW
#MedicalNicotine

"Transdermal nicotine ...improves symptoms in patients with ulcerative colitis."
https://t.co/wY6PUlDqL6

"Complete resolution of symptoms was observed in 48.6% of cases with nicotine and only in 24.3% of cases with placebo."
https://t.co/iVZqgnojR0
#MedicalNicotine for #COVID19?

"Compared with never smokers, current smokers appear to be at reduced risk of SARS‐CoV‐2 infection, while former smokers appear to be at increased risk of hospitalization, disease severity and mortality from COVID‐19."
https://t.co/wuP4SZmN7m
#MedicalNicotine THREAD
👆👆👆👆👆

Nicotine has therapeutic benefits for #StopSmoking; #ParkinsonsDisease; #Alzheimers #Dementia; #ADHD; #MentalHealth; #Tourettes; #UlcerativeColitis; #Schizophrenia; #Epilepsy; #weightloss; and, possibly, preventing #coronavirus infection

More from Health

Before we get too far into 2021, I thought I’d write a thread recapping some of the research that came out of my lab in 2020. Most of this work was led by my talented team of graduate students, Kerrianne Morrison, @kmdebrabander, and @DesiRJones.

Back in January, a news story was published about Kerrianne’s study showing improved social interaction outcomes for autistic adults when paired with another autistic partner.

A detailed thread about the study and a link to the paper can be found here (feel free to DM me your email address if you’d like a copy of the full paper for this study or any of our studies):


Another paper published early in 2020 (it appeared a few months earlier online) showed that traditional standalone tasks of social cognition are less predictive of functional and social skills among autistic adults than commonly assumed in autism research.


Next, @kmdebrabander led and published an innovative study about how well autistic and non-autistic adults can predict their own cognitive and social cognitive performance.

You May Also Like